Bicara Therapeutics Inc. (BCAX) stock
BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.60−0.15 (-1.54%)
Close on Nov 17, 2026Market cap $635.26MP/E –Yield –
Bicara Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Bicara Therapeutics's price to book ratio was 1.5× on Nov 11, 2026, against 2.5× a year earlier. Over the last 2 years it ranged from 1.1× to 3.8×, with a median of 2.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.5× | −0.8 |
| 2025 | Dec 31, 2025 | 2.3× | +0.4 |
| 2024 | Dec 31, 2024 | 1.9× | – |
See a number that looks wrong?